Statistics Portugal - Web Portal
Official Portal - Statistics Portugal

  List - Navigation Tree - Navigation  


Utilizar as setas para ordenar as colunas.
Indicators Database table
  Indicators Reference period Date of update   Geographical Level(*)    
Initial Last
  Sort asc/desc Sort asc/desc Sort asc/desc Sort asc/desc   Sort asc/desc    
Consult associated metadata Potential years of life lost due to diseases of the respiratory system (Years) by Place of residence (NUTS - 2013) and Sex; Annual 2002 2017 11-07-2019   NUTS II   Login for subscription
Consult associated metadata Standardized mortality rate (65 and more years) due to cerebrovascular diseases per 100 000 inhabitants (No.) by Place of residence (NUTS - 2013) and Sex; Annual 2009 2017 11-07-2019   NUTS II   Login for subscription
Consult associated metadata Rate of potential years of life lost due to human immunodeficiency virus (HIV) disease per 100 000 inhabitants (No.) by Place of residence (NUTS - 2013) and Sex; Annual 2009 2017 11-07-2019   NUTS II   Login for subscription
Consult associated metadata Standardized mortality rate due to malignant neoplasms of digestive organs and peritoneum per 100 000 inhabitants (No.) by Place of residence (NUTS - 2013) and Sex; Annual 2002 2017 11-07-2019   NUTS II   Login for subscription
Consult associated metadata Potential years of life lost due to ischaemic heart diseases (Years) by Place of residence (NUTS - 2013) and Sex; Annual 2002 2017 11-07-2019   NUTS II   Login for subscription
Consult associated metadata Potential years of life lost due to diseases of the circulatory system (Years) by Place of residence (NUTS - 2013) and Sex; Annual 2002 2017 11-07-2019   NUTS II   Login for subscription
Consult associated metadata Standardized mortality rate (65 and more years) due to malignant neoplasm of prostate per 100 000 inhabitants (No.) by Place of residence (NUTS - 2013); Annual 2009 2017 11-07-2019   NUTS II   Login for subscription
Consult associated metadata Standardized mortality rate (65 and more years) due to malignant neoplasm of the genitourinary organs per 100 000 inhabitants (No.) by Place of residence (NUTS - 2013) and Sex; Annual 2009 2017 11-07-2019   NUTS II   Login for subscription
Consult associated metadata Standardized mortality rate (65 and more years) due to malignant neoplasm of cervix uteri per 100 000 inhabitants (No.) by Place of residence (NUTS - 2013); Annual 2009 2017 11-07-2019   NUTS II   Login for subscription
Consult associated metadata Standardized mortality rate (less than 65 years) due to malignant neoplasm of bronchus and lung per 100 000 inhabitants (No.) by Place of residence (NUTS - 2013) and Sex; Annual 2009 2017 11-07-2019   NUTS II   Login for subscription
Consult associated metadata Standardized mortality rate (65 and more years) due to symptoms and signs, abnormal results and not well defined causes per 100 000 inhabitants (No.) by Place of residence (NUTS - 2013) and Sex; Annual 2009 2017 11-07-2019   NUTS II   Login for subscription
Consult associated metadata Mortality rate due to tuberculosis per 100 000 inhabitants (No.) by Place of residence (NUTS - 2013), Sex and Age group; Annual 2009 2017 11-07-2019   NUTS II   Login for subscription
Consult associated metadata Mortality rate due to malignant neoplasm of liver and intrahepatic bile ducts per 100 000 inhabitants (No.) by Place of residence (NUTS - 2013), Sex and Age group; Annual 2009 2017 11-07-2019   NUTS II   Login for subscription
Consult associated metadata Standardized mortality rate (less than 65 years) due to Alzheimer''s disease per 100 000 inhabitants (No.) by Place of residence (NUTS - 2013) and Sex; Annual 2009 2017 11-07-2019   NUTS II   Login for subscription
Consult associated metadata Standardized mortality rate (less than 65 years) due to malignant neoplasm of pancreas per 100 000 inhabitants (No.) by Place of residence (NUTS - 2013) and Sex; Annual 2009 2017 11-07-2019   NUTS II   Login for subscription
<< <     of 859 > >>
(*) Lower geographic detail level, or equivalent, for which data is available.